Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
January 21, 2025 at 14:35 PM EST
Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and Goliath dynamic” in 2024, report says.
